Patents by Inventor Leonard Walter Rozamus, Jr.

Leonard Walter Rozamus, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of a selective c-kit kinase inhibitor
    Patent number: 11767319
    Abstract: The present disclosure relates generally to various forms and compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: September 26, 2023
    Assignee: Third Harmonic Bio, Inc.
    Inventors: Gregg F. Keaney, Leonard Walter Rozamus, Jr., Jonathan James Loughrey, Jaclyn Raeburn, Yuxiang Song
  • CRYSTALLINE FORMS OF A SELECTIVE C-KIT KINASE INHIBITOR
    Publication number: 20220056026
    Abstract: The present disclosure relates generally to various forms and compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
    Type: Application
    Filed: July 15, 2021
    Publication date: February 24, 2022
    Applicant: Third Harmonic Bio, Inc.
    Inventors: Gregg F. Keaney, Leonard Walter Rozamus, JR., Jonathan James Loughrey, Jaclyn Raeburn, Yuxiang Song
  • Rapamycin derivatives
    Patent number: 5661156
    Abstract: Rapamycin derivatives of formula ##STR1## pharmaceutical compositions comprising such rapamycin derivatives and pharmaceutically acceptable carriers or diluents; and methods of using such derivatives to inhibit pathogenic fungal growth, cause therapeutically desirable immunosuppression, or treat carcinogenic tumors are disclosed.
    Type: Grant
    Filed: March 6, 1995
    Date of Patent: August 26, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: Dennis Alan Holt, Juan Ignacio Luengo, Leonard Walter Rozamus, Jr.
  • Rapamycin derivatives
    Patent number: 5648361
    Abstract: Rapamycin derivatives; pharmaceutical compositions comprising such rapamycin derivatives and pharmaceutically acceptable carriers or diluents; and methods of using such derivatives to inhibit pathogenic fungi growth, inhibit immunosuppression or treat carcinogenic tumors are disclosed.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: July 15, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: Dennis Alan Holt, Juan Ignacio Luengo, Leonard Walter Rozamus, Jr.
  • Rapamycin derivatives
    Patent number: RE37421
    Abstract: Rapamycin derivatives; pharmaceutical compositions comprising such rapamycin derivatives and pharmaceutically acceptable carriers or diluents; and methods of using such derivatives to inhibit pathogenic fungi growth, inhibit immunosuppression or treat carcinogenic tumors are disclosed.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 23, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Dennis Alan Holt, Juan Ignacio Luengo, Leonard Walter Rozamus, Jr.